AxoGen Announces RECON® Study Update
Study Supports Company’s Planned Biologic License Application (BLA) for Avance® Nerve Graft ALACHUA, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) — […]
Study Supports Company’s Planned Biologic License Application (BLA) for Avance® Nerve Graft ALACHUA, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) — […]
MENLO PARK, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing […]
NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) — Tyme Technologies, Inc. (NASDAQ: TYME), a clinical-stage oncology biotechnology company developing metabolically-based […]
Sales Increase of 212% Compared to Prior Year TAMPA, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) — MagneGas Applied Technology Solutions, […]
IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical […]
MIAMI, Jan. 15, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that […]
HINGHAM, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the […]
Plenary Session and Presentation entitled “Status of Cellular Therapy and Regenerative Medicine in China” FREEHOLD, N.J., Jan. 15, 2019 (GLOBE […]
New recommendations highlight positive changes for PACE participants MOORESTOWN, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. […]
EL SEGUNDO, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership” or “Landmark”) (NASDAQ: LMRK) announced […]